Literature DB >> 8294510

Disruption of pre-mRNA splicing in vivo results in reorganization of splicing factors.

R T O'Keefe1, A Mayeda, C L Sadowski, A R Krainer, D L Spector.   

Abstract

We have examined the functional significance of the organization of pre-mRNA splicing factors in a speckled distribution in the mammalian cell nucleus. Upon microinjection into living cells of oligonucleotides or antibodies that inhibit pre-mRNA splicing in vitro, we observed major changes in the organization of splicing factors in vivo. Interchromatin granule clusters became uniform in shape, decreased in number, and increased in both size and content of splicing factors, as measured by immunofluorescence. These changes were transient and the organization of splicing factors returned to their normal distribution by 24 h following microinjection. Microinjection of these oligonucleotides or antibodies also resulted in a reduction of transcription in vivo, but the oligonucleotides did not inhibit transcription in vitro. Control oligonucleotides did not disrupt splicing or transcription in vivo. We propose that the reorganization of splicing factors we observed is the result of the inhibition of splicing in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8294510      PMCID: PMC2119927          DOI: 10.1083/jcb.124.3.249

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  87 in total

1.  Intracellular distribution of microinjected antisense oligonucleotides.

Authors:  J P Leonetti; N Mechti; G Degols; C Gagnor; B Lebleu
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

2.  Purification and characterization of pre-mRNA splicing factor SF2 from HeLa cells.

Authors:  A R Krainer; G C Conway; D Kozak
Journal:  Genes Dev       Date:  1990-07       Impact factor: 11.361

3.  Identification, purification, and biochemical characterization of U2 small nuclear ribonucleoprotein auxiliary factor.

Authors:  P D Zamore; M R Green
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

4.  Splicing of messenger RNA precursors is inhibited by antisera to small nuclear ribonucleoprotein.

Authors:  R A Padgett; S M Mount; J A Steitz; P A Sharp
Journal:  Cell       Date:  1983-11       Impact factor: 41.582

5.  A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro.

Authors:  H Ge; J L Manley
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

6.  Oligonucleotide-targeted degradation of U1 and U2 snRNAs reveals differential interactions of simian virus 40 pre-mRNAs with snRNPs.

Authors:  Z Q Pan; H Ge; X Y Fu; J L Manley; C Prives
Journal:  Nucleic Acids Res       Date:  1989-08-25       Impact factor: 16.971

7.  Normal and mutant human beta-globin pre-mRNAs are faithfully and efficiently spliced in vitro.

Authors:  A R Krainer; T Maniatis; B Ruskin; M R Green
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

8.  Higher level organization of individual gene transcription and RNA splicing.

Authors:  Y Xing; C V Johnson; P R Dobner; J B Lawrence
Journal:  Science       Date:  1993-02-26       Impact factor: 47.728

9.  Multiple domains of U1 snRNA, including U1 specific protein binding sites, are required for splicing.

Authors:  J Hamm; N A Dathan; D Scherly; I W Mattaj
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

10.  The regulation of RNA synthesis and processing in the nucleolus during inhibition of protein synthesis.

Authors:  M Willems; M Penman; S Penman
Journal:  J Cell Biol       Date:  1969-04       Impact factor: 10.539

View more
  85 in total

1.  Nuclear pre-mRNA compartmentalization: trafficking of released transcripts to splicing factor reservoirs.

Authors:  I Melcák; S Cermanová; K Jirsová; K Koberna; J Malínský; I Raska
Journal:  Mol Biol Cell       Date:  2000-02       Impact factor: 4.138

2.  Prespliceosomal assembly on microinjected precursor mRNA takes place in nuclear speckles.

Authors:  I Melcák; S Melcáková; V Kopský; J Vecerová; I Raska
Journal:  Mol Biol Cell       Date:  2001-02       Impact factor: 4.138

3.  A direct role of SRY and SOX proteins in pre-mRNA splicing.

Authors:  Kenji Ohe; Enzo Lalli; Paolo Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

4.  RNA polymerase III transcripts and the PTB protein are essential for the integrity of the perinucleolar compartment.

Authors:  Chen Wang; Joan C Politz; Thoru Pederson; Sui Huang
Journal:  Mol Biol Cell       Date:  2003-06       Impact factor: 4.138

5.  Use of fluorescent protein tags to study nuclear organization of the spliceosomal machinery in transiently transformed living plant cells.

Authors:  Zdravko J Lorković; Julia Hilscher; Andrea Barta
Journal:  Mol Biol Cell       Date:  2004-05-07       Impact factor: 4.138

Review 6.  Nuclear speckles.

Authors:  David L Spector; Angus I Lamond
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-02-01       Impact factor: 10.005

7.  Regulated cellular partitioning of SR protein-specific kinases in mammalian cells.

Authors:  Jian-Hua Ding; Xiang-Yang Zhong; Jonathan C Hagopian; Marissa M Cruz; Gourisankar Ghosh; James Feramisco; Joseph A Adams; Xiang-Dong Fu
Journal:  Mol Biol Cell       Date:  2005-11-30       Impact factor: 4.138

8.  Basonuclins 1 and 2, whose genes share a common origin, are proteins with widely different properties and functions.

Authors:  Amandine Vanhoutteghem; Philippe Djian
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-04       Impact factor: 11.205

9.  Novel splicing factor RBM25 modulates Bcl-x pre-mRNA 5' splice site selection.

Authors:  Anyu Zhou; Alexander C Ou; Aeri Cho; Edward J Benz; Shu-Ching Huang
Journal:  Mol Cell Biol       Date:  2008-07-28       Impact factor: 4.272

10.  RNAi knockdown of hPrp31 leads to an accumulation of U4/U6 di-snRNPs in Cajal bodies.

Authors:  Nina Schaffert; Markus Hossbach; Rainer Heintzmann; Tilmann Achsel; Reinhard Lührmann
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.